Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.82 USD | +1.33% | -1.99% | -13.77% |
02-08 | Transcript : Bioceres Crop Solutions Corp., Q2 2024 Earnings Call, Feb 08, 2024 | |
02-08 | Bioceres Crop Solutions Corp. Reports Earnings Results for the Second Quarter Ended December 31, 2023 | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-13.77% | 733M | - | ||
+19.85% | 37.68B | C | ||
-4.36% | 7.21B | A | ||
+3.64% | 6.64B | B- | ||
-5.50% | 5.86B | B+ | ||
-3.05% | 5.69B | B | ||
-11.31% | 5.54B | - | C- | |
+29.81% | 5.13B | B- | ||
-15.16% | 4.56B | C+ | ||
+7.50% | 3.87B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BIOX Stock
- Ratings Bioceres Crop Solutions Corp.